You are here:Home1/News Release2/Anticancer Agent LENVIMA? Approved for Additional Indication of Unresectable Hepatocellular Carcinoma (HCC) in Japan, First Approval Worldwide for LENVIMA for HCC
/wordpress/wp-content/uploads/2021/04/logo3.png00chen, chenyan/wordpress/wp-content/uploads/2021/04/logo3.pngchen, chenyan2018-03-23 00:00:002021-03-19 10:25:03Anticancer Agent LENVIMA? Approved for Additional Indication of Unresectable Hepatocellular Carcinoma (HCC) in Japan, First Approval Worldwide for LENVIMA for HCC